SABRINA FALKNER

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology SNELLVILLE, GA NPI 1346288271

General Payments — all program years on this page

$1,816.57

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 83
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $415.77 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $375.7220
Education $40.052

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $297.0721
2019 $230.8014
2020 $50.103
2021 $16.531
2022 $238.9011
2023 $567.4011
2024 $415.7722

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086182737 Bayer Healthcare Pharmaceuticals Inc. $13.35 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096953932 Novo Nordisk Inc $20.08 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096967113 Novo Nordisk Inc $23.86 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097363947 Novo Nordisk Inc $20.45 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097628405 Novo Nordisk Inc $18.95 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103707559 ABBVIE INC. $16.32 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120626841 Baxter Healthcare $17.22 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135360556 Lilly USA, LLC $15.31 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135408271 Lilly USA, LLC $21.27 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136307759 Organon Llc $23.57 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136313209 Organon Llc $14.96 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139335844 Astellas Pharma US Inc $15.84 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139391314 Astellas Pharma US Inc $19.39 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139430290 Astellas Pharma US Inc $16.14 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139439596 Astellas Pharma US Inc $23.91 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148849895 Sumitomo Pharma America, Inc. $27.42 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148849897 Sumitomo Pharma America, Inc. $16.76 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149992737 Exeltis, USA Inc. $15.00 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149992739 Exeltis, USA Inc. $16.68 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150795871 CooperSurgical, Inc. $19.24 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150906776 MILLICENT US INC $26.70 12/04/2024 Education Undisputed 01/23/2026 View at CMS
1150906778 MILLICENT US INC $13.35 12/18/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.